Abstract
Secondary lymphoid chemokine (SLC) attracts mature dendritic cells (DCs) and naïve T cells. Co-localization of these cells within local tumor environments may enhance the induction of tumor-specific T cells. However, the presence of danger signals or other DC maturation signals are required to optimize T-cell priming. We hypothesized that expression of SLC in vaccinia virus would provide local chemokine delivery and adjuvant factors. A recombinant vaccinia virus expressing murine SLC (rVmSLC) was constructed and characterized. SLC expression was confirmed by Western blot analysis and functional activity was determined by in vitro chemotaxis assay. Supernatants from rVmSLC-infected cells attracted CD4 T cells, and also induced the migration of CD8 T cells and DCs. Although poxviruses are known to express several chemokine-binding proteins, systemic injection of rVmSLC was well tolerated in mice up to a dose of 1 x 10(7) pfu and did not significantly alter vaccinia-specific T-cell immunity. Local injection of rVmSLC into established tumors derived from the murine colon cancer line, CT26, resulted in enhanced infiltration of CD4 T cells, which correlated with inhibition of tumor growth. The central role of CD4 T cells was further ...Continue Reading
References
Jun 21, 1991·Science·B Moss
Jan 1, 1996·Virology·K MossmanG McFadden
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·B Moss
Feb 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·M D GunnL T Williams
Jun 20, 1998·The Journal of Cell Biology·J J CampbellE C Butcher
Sep 9, 1998·The Journal of Experimental Medicine·B BodaghiS Michelson
Jan 6, 2000·The Journal of Experimental Medicine·H R LüttichauT W Schwartz
May 16, 2000·Human Gene Therapy·H L KaufmanM J Surhland
Jun 3, 2000·Annual Review of Immunology·F SallustoA Lanzavecchia
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·H XiaoK T Jeang
Nov 9, 2000·Proceedings of the National Academy of Sciences of the United States of America·S A LutherJ G Cyster
Jan 4, 2001·Immunological Reviews·F Sallusto, A Lanzavecchia
Jan 10, 2001·The Journal of Experimental Medicine·S MoriT Kakiuchi
Feb 28, 2001·Cancer Immunology, Immunotherapy : CII·D A ArenbergR M Strieter
Mar 27, 2001·International Journal of Cancer. Journal International Du Cancer·T NomuraS Fujita
Aug 4, 2001·Human Gene Therapy·H L KaufmanM Voulo
Sep 12, 2001·The Journal of Biological Chemistry·C G BeckR Urfer
Mar 20, 2002·Cytokine & Growth Factor Reviews·Alain P Vicari, Christophe Caux
Mar 27, 2002·Nature Reviews. Immunology·Bernhard HomeyAlbert Zlotnik
Jun 19, 2002·Cancer Immunology, Immunotherapy : CII·Liviu V TituJohn Greenman
Jun 26, 2002·Annals of the New York Academy of Sciences·Polly Matzinger
Sep 13, 2002·Immunology and Cell Biology·Shaun R McColl
Sep 21, 2002·The Prostate·James GulleyJ Michael Hamilton
Citations
Sep 6, 2012·Immunotherapy·Elham Mohit, Sima Rafati
Mar 9, 2012·Advances in Virology·Mark S FergusonYaohe Wang
Aug 25, 2007·Cancer Metastasis Reviews·Simi Ali, Gwendal Lazennec
Sep 25, 2007·Pharmaceutical Research·Jian-Qing GaoShinsaku Nakagawa
Sep 1, 2006·Human Gene Therapy·Lina ElzaoukKarin Moelling
Feb 13, 2010·Cancer Gene Therapy·C Jackaman, D J Nelson
May 13, 2008·Immunobiology·Sha WuGuanxin Shen
Jun 10, 2006·Hematology/oncology Clinics of North America·Andrew EisenbergerHoward L Kaufman
May 28, 2005·Cellular Immunology·Kenneth FlanaganHoward L Kaufman
Mar 3, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Barrett J Rollins
Jun 15, 2007·International Reviews of Immunology·Robert C Ward, Howard L Kaufman